3,472 results on '"Glimelius, Bengt"'
Search Results
2. Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort
3. Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
4. ASO Visual Abstract: Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort
5. Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
6. Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
7. Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
8. Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer: A Nested Case-control Matched Analysis of an International, Multi-centre, Randomised Controlled Trial (FOxTROT)
9. The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study
10. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
11. Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
12. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
13. Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
14. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
15. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial
16. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study
17. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
18. Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus
19. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes
20. Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery – A Five-year Follow-up of the RAPIDO Trial
21. Multidisciplinary Treatment of Rectal Cancer
22. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients
23. Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
24. Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis
25. Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma
26. Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma
27. Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)
28. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
29. Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts
30. Comment on the RAPIDO Trial Point-Counterpoint Debate
31. Implications of pretreatment extramural venous invasion in rectal cancer patients : a population-based study
32. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
33. Recent advances in rectal cancer treatment : are we on the right track?
34. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
35. Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
36. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
37. The Swedish Approach
38. Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)
39. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
40. Incidence patterns of colorectal cancer in Norway 1993-2022 by age, site, and morphology.
41. Oncological Outcomes after a Pathological Complete Response Following Total Neoadjuvant Therapy or Chemoradiotherapy for High-Risk Locally Advanced Rectal Cancer in the RAPIDO Trial
42. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
43. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
44. A genome-wide association study of marginal zone lymphoma shows association to the HLA region.
45. How Long to Wait After Preoperative Radio(Chemo) Therapy to Perform Surgery?
46. Will Adjuvant Chemotherapy Improve Outcome After Preoperative (Chemo) Radiotherapy? Still More Passion than Evidence
47. What Are the Present Recommendations for Short-Course Preoperative Radiotherapy (RT) and Delayed Surgery?
48. Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study
49. Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines
50. Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.